Scholars Central

EditorialPublished 27 May 2024

Biological Barriers to Drug Delivery: Overcoming Challenges in Biopharmaceutics

Authors: Vijay Kumar Paudel

Department of Pharmaceutical Sciences, School of Health and Allied Sciences, Pokhara University, Pokhara, Nepal

Clinical Pharmacology & Biopharmaceutics

Volume 13 · Issue 5 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The delivery of therapeutic agents is often hindered by various biological barriers that impede their absorption, distribution, metabolism, and excretion. This article explores the primary physiological, cellular, and molecular barriers to drug delivery, including the gastrointestinal tract, blood-brain barrier, mucosal barriers, cell membranes, efflux transporters, and enzymatic degradation. It also examines the immune response as a significant challenge in the delivery of biologics. To address these challenges, several innovative strategies are discussed, such as nanoparticlebased drug delivery, prodrug approaches, transporter inhibition, peptide and protein modification, chemical penetration enhancers, BBB penetration carriers, and mucus-penetrating particles. These advancements aim to enhance drug stability, bioavailability, and targeted delivery, ultimately improving therapeutic efficacy and patient outcomes. As the field of biopharmaceutics evolves, overcoming these biological barriers remains crucial for the development of more effective treatments for various diseases

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Vijay Kumar Paudel”